DE2338833A1 - Fuer pharmazeutische und/oder kosmetische zwecke brauchbares lichtschutzpraeparat - Google Patents
Fuer pharmazeutische und/oder kosmetische zwecke brauchbares lichtschutzpraeparatInfo
- Publication number
- DE2338833A1 DE2338833A1 DE19732338833 DE2338833A DE2338833A1 DE 2338833 A1 DE2338833 A1 DE 2338833A1 DE 19732338833 DE19732338833 DE 19732338833 DE 2338833 A DE2338833 A DE 2338833A DE 2338833 A1 DE2338833 A1 DE 2338833A1
- Authority
- DE
- Germany
- Prior art keywords
- light protection
- light
- preparation according
- those
- protection preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims description 60
- 239000002537 cosmetic Substances 0.000 title claims description 12
- 230000001681 protective effect Effects 0.000 title description 2
- 230000004224 protection Effects 0.000 claims description 45
- 239000000126 substance Substances 0.000 claims description 22
- 150000001875 compounds Chemical class 0.000 claims description 16
- 239000004480 active ingredient Substances 0.000 claims description 9
- 239000002245 particle Substances 0.000 claims description 7
- -1 especially cathyl Chemical group 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 239000000460 chlorine Substances 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 150000002367 halogens Chemical class 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 239000006260 foam Substances 0.000 claims description 2
- 239000007789 gas Substances 0.000 claims description 2
- 239000004922 lacquer Substances 0.000 claims description 2
- 230000031700 light absorption Effects 0.000 claims description 2
- 230000035699 permeability Effects 0.000 claims description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 229910052740 iodine Inorganic materials 0.000 claims 1
- 239000011630 iodine Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 description 16
- 230000005855 radiation Effects 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000002966 varnish Substances 0.000 description 10
- 238000010521 absorption reaction Methods 0.000 description 9
- 230000009931 harmful effect Effects 0.000 description 8
- 206010015150 Erythema Diseases 0.000 description 7
- YHCGGLXPGFJNCO-UHFFFAOYSA-N 2-(2H-benzotriazol-4-yl)phenol Chemical class OC1=CC=CC=C1C1=CC=CC2=C1N=NN2 YHCGGLXPGFJNCO-UHFFFAOYSA-N 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 6
- 231100000321 erythema Toxicity 0.000 description 6
- 230000003810 hyperpigmentation Effects 0.000 description 6
- 239000002674 ointment Substances 0.000 description 6
- 208000000069 hyperpigmentation Diseases 0.000 description 5
- 230000037072 sun protection Effects 0.000 description 5
- 208000012641 Pigmentation disease Diseases 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 206010041303 Solar dermatitis Diseases 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 150000008366 benzophenones Chemical class 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000009610 hypersensitivity Effects 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000000258 photobiological effect Effects 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 230000019612 pigmentation Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 230000000475 sunscreen effect Effects 0.000 description 3
- 239000000516 sunscreening agent Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- RMSGQZDGSZOJMU-UHFFFAOYSA-N 1-butyl-2-phenylbenzene Chemical group CCCCC1=CC=CC=C1C1=CC=CC=C1 RMSGQZDGSZOJMU-UHFFFAOYSA-N 0.000 description 2
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 206010034972 Photosensitivity reaction Diseases 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 206010040914 Skin reaction Diseases 0.000 description 2
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 230000003851 biochemical process Effects 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000002316 cosmetic surgery Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical class CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000003883 ointment base Substances 0.000 description 2
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 2
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000003973 paint Substances 0.000 description 2
- 230000003950 pathogenic mechanism Effects 0.000 description 2
- 230000036211 photosensitivity Effects 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920002037 poly(vinyl butyral) polymer Polymers 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 239000011814 protection agent Substances 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 230000035483 skin reaction Effects 0.000 description 2
- 231100000430 skin reaction Toxicity 0.000 description 2
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 2
- 239000001570 sorbitan monopalmitate Substances 0.000 description 2
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229960002117 triamcinolone acetonide Drugs 0.000 description 2
- YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 210000002268 wool Anatomy 0.000 description 2
- WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical class C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 1
- NGKNMHFWZMHABQ-UHFFFAOYSA-N 4-chloro-2h-benzotriazole Chemical class ClC1=CC=CC2=NNN=C12 NGKNMHFWZMHABQ-UHFFFAOYSA-N 0.000 description 1
- 229910002019 Aerosil® 380 Inorganic materials 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010004950 Birth mark Diseases 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 208000035874 Excoriation Diseases 0.000 description 1
- 206010073306 Exposure to radiation Diseases 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- 206010027146 Melanoderma Diseases 0.000 description 1
- 241000209295 Melanoderma Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010036087 Polymorphic light eruption Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010039580 Scar Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 239000004098 Tetracycline Chemical class 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 230000037374 absorbed through the skin Effects 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 239000007765 cera alba Substances 0.000 description 1
- KYKAJFCTULSVSH-UHFFFAOYSA-N chloro(fluoro)methane Chemical compound F[C]Cl KYKAJFCTULSVSH-UHFFFAOYSA-N 0.000 description 1
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 1
- 229960001076 chlorpromazine Drugs 0.000 description 1
- 230000007665 chronic toxicity Effects 0.000 description 1
- 231100000160 chronic toxicity Toxicity 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000035614 depigmentation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 230000001795 light effect Effects 0.000 description 1
- 239000004611 light stabiliser Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 229950000688 phenothiazine Drugs 0.000 description 1
- 230000002165 photosensitisation Effects 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 description 1
- 239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000009979 protective mechanism Effects 0.000 description 1
- 239000002534 radiation-sensitizing agent Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 206010041307 solar urticaria Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229930101283 tetracycline Chemical class 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 229940045860 white wax Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/496—Triazoles or their condensed derivatives, e.g. benzotriazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- C07D249/18—Benzotriazoles
- C07D249/20—Benzotriazoles with aryl radicals directly attached in position 2
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HURI000473 HU164662B (enExample) | 1972-07-31 | 1972-07-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2338833A1 true DE2338833A1 (de) | 1974-02-14 |
Family
ID=11000895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19732338833 Pending DE2338833A1 (de) | 1972-07-31 | 1973-07-31 | Fuer pharmazeutische und/oder kosmetische zwecke brauchbares lichtschutzpraeparat |
Country Status (5)
| Country | Link |
|---|---|
| CH (1) | CH583560A5 (enExample) |
| DE (1) | DE2338833A1 (enExample) |
| FR (1) | FR2194442A1 (enExample) |
| HU (1) | HU164662B (enExample) |
| NL (1) | NL7310246A (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002528475A (ja) * | 1998-11-02 | 2002-09-03 | チバ スペシャルティ ケミカルズ ホールディング インコーポレーテッド | ボディケア製品及び家庭用製品の安定化 |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1043495A (fr) * | 1976-07-29 | 1978-11-28 | Bernard Jacquet | Polymeres anti-solaires et compositions cosmetiques les contenant |
| GB9403451D0 (en) * | 1994-02-23 | 1994-04-13 | Ciba Geigy Ag | Sunscreen compositions |
| KR100496318B1 (ko) | 1996-11-22 | 2005-06-20 | 시바 스페셜티 케미칼스 홀딩 인크. | 사람 및 동물의 피부 및 모발을 자외선의 유해한 영향으로부터보호하기 위한, 선택된 벤조트리아졸 유도체의 용도 |
| US6908608B1 (en) | 1998-11-02 | 2005-06-21 | Ciba Specialty Chemical Corporation | Stabilization of body-care and household products |
| US6296674B1 (en) * | 2000-02-01 | 2001-10-02 | Ciba Specialty Chemicals Corporation | Candle wax stabilized with red-shift benzotriazoles |
| JP5588676B2 (ja) * | 2006-07-27 | 2014-09-10 | チバ ホールディング インコーポレーテッド | 紫外線の悪影響からヒト又は動物の皮膚又は毛髪を保護するためのアミノフェニルベンゾトリアゾール誘導体の使用及びその化粧品組成物。 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3004896A (en) * | 1956-12-14 | 1961-10-17 | Geigy Ag J R | Ultra-violet light-absorbing composition of matter |
| BE563210A (enExample) * | 1956-12-14 | 1958-06-13 | ||
| US3644127A (en) * | 1969-09-16 | 1972-02-22 | Gen Foods Corp | Production of solid flavoring compositions |
-
1972
- 1972-07-31 HU HURI000473 patent/HU164662B/hu unknown
-
1973
- 1973-07-13 CH CH1023373A patent/CH583560A5/xx not_active IP Right Cessation
- 1973-07-23 NL NL7310246A patent/NL7310246A/xx unknown
- 1973-07-31 FR FR7328036A patent/FR2194442A1/fr active Granted
- 1973-07-31 DE DE19732338833 patent/DE2338833A1/de active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002528475A (ja) * | 1998-11-02 | 2002-09-03 | チバ スペシャルティ ケミカルズ ホールディング インコーポレーテッド | ボディケア製品及び家庭用製品の安定化 |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2194442B1 (enExample) | 1976-10-22 |
| CH583560A5 (enExample) | 1977-01-14 |
| FR2194442A1 (en) | 1974-03-01 |
| HU164662B (enExample) | 1974-03-28 |
| NL7310246A (enExample) | 1974-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69725843T2 (de) | Mittel zur verwendung in der phototherapeutischen behandlung proliferativer hautstörungen | |
| DE4444238A1 (de) | Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden | |
| DE3441636A1 (de) | Neue chalkonderivate und ultraviolett-absorber mit einem gehalt derselben | |
| DE1492438A1 (de) | Eine duenne Schutzschicht bildendes kosmetisches Material | |
| EP0898955A2 (de) | Sonnenschutzmittel mit Ultraspektralschutz | |
| CH644756A5 (de) | Sonnenschutzzubereitungen und ihre verwendung. | |
| DE4305788A1 (de) | Synergistische Lichtschutzkombinationen und kosmetische und dermatologische Formulierungen, solche Kombinationen enthaltend | |
| DE19504398A1 (de) | Tocopherylglycoside, ihre Herstellung sowie ihre Verwendung als Tenside, als Antioxidantien sowie als der Zellalterung vorbeugender Wirkstoff in kosmetischen oder pharmazeutischen Zubereitungen | |
| EP1030649B1 (de) | Lichtstabile kosmetische formulierung enthaltend butylmethoxydibenzoylmethan | |
| EP1063959A1 (de) | Sonnenschutzformulierungen mit wirkung gegen herpes simplex viren | |
| WO2014183973A1 (de) | Stabilisierte zubereitungen mit einem gehalt an ascorbinsäure und phosphationen | |
| WO2015135606A1 (de) | Kosmetische oder dermatologische zubereitungen mit einem gehalt an decalinderivaten und verwendung von decalinderivaten zur bräunung der haut | |
| DE102014203011A1 (de) | Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an einem oder mehreren Biphenylamin-Derivaten und Verwendung von einem oder mehreren Biphenylamin-Derivaten zur Bräunung der Haut | |
| DE102013208880A1 (de) | Stabilisierte Zubereitungen mit einem Gehalt an Ascorbinsäure und Gemischen aus Natriumstearoylglutamat und/oder Cetylstearylsulfat in Kombination mit Glycerylstearat | |
| DE2032914A1 (enExample) | ||
| KR100871911B1 (ko) | 자외선 차단 화장료 조성물 | |
| DE3408406A1 (de) | Licht- und sonnenschutzmittel | |
| DE60120159T2 (de) | Hautpflegemittel | |
| EP2421502A2 (de) | Verwendung von glycyrrhetinsäure und/oder deren derivaten zur herstellung kosmetischer oder dermatologischer zubereitungen zur prophylaxe von schäden an der hauteigenen dna und/oder zur reparatur bereits eingetretener schäden an der hauteigenen dna | |
| DE68910502T2 (de) | Ultraviolett absorbierendes kosmetikum. | |
| EP1834631B1 (de) | Kosmetische oder dermatologische Zubereitungen enthaltend Glycyrrhetin und/oder Glycyrrhizin sowie Glucosederivate bzw. Glycerinether | |
| DE69329487T2 (de) | Mittel zur topischen Anwendung auf der Haut zur Behandlung und/oder zur Verhütung von, durch Strahlen verursachten Hautschäden | |
| DE69502854T2 (de) | Zusammensetzung zur Bekämpfung von Hautflecken und/oder Hautalterung und ihre Verwendungen | |
| EP0620000A2 (de) | Kosmetische und/oder pharmazeutische Verwendung von N-Acylalkanolaminen | |
| DE19856947A1 (de) | Sonnenschutzmittel |